GSK Plc has broadened its artificial-intelligence partnership with UK biotech Relation Therapeutics Ltd., agreeing to a collaboration that could pay the startup as much as $110 million in upfront and success-based milestone payments as the pharmaceutical giant seeks to accelerate early-stage drug discovery.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.